BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 18, 2006
View Archived Issues
Pro-antioxidant effects of resveratrol in cardiovascular tissue
Read More
Targeting Hsp90 to selectively degrade mutated B-Raf for melanoma
Read More
Procyon receives NRC-IRAP contribution for development of PPL-100
Read More
FDA approves CIP-Fenofibrate
Read More
Genelabs discusses Prestara development options with FDA
Read More
Evotec and Boehringer Ingelheim expand drug discovery collaboration
Read More
4SC and Sanwa Kagaku Kenkyusho achieve drug discovery collaboration milestone
Read More
Avigen signs North American deal for neuroactive compound
Read More
Positive findings in phase III study of Pennsaid
Read More
Clearance for phase I study of PRX-302 in prostate cancer
Read More
Series D financing at Symphogen
Read More
NMDA NR2B receptors contribute to behavioral sensitization evoked by inflammation
Read More
Ropinirole efficacy in restless legs syndrome affirmed in large trial
Read More
Letrozole superior to tamoxifen in postmenopausal women with breast cancer
Read More
Oral contraceptives may lead to sex hormone-binding globulin elevation
Read More
Inhaled ciclosporin added to immunosuppression beneficial in lung transplant patients
Read More
Medicure reports corporate highlights from quarter
Read More
Recent patents report new treatments for thrombotic disorders
Read More
Fast track designation for peramivir in the treatment of influenza infections
Read More
Novel CCR4 receptor modulators emerge from Astellas R&D
Read More
European roll-out of Serdolect begins in Estonia
Read More
Agents with potential for HIV infection treatment revealed in recent patents
Read More
First pure heart rate-lowering agent launched in Ireland
Read More